Comparative Pharmacokinetics, Pharmacodynamics, and Tolerability of Ertapenem 1 Gram/Day Administered as a Rapid 5-Minute Infusion versus the Standard 30-Minute Infusion in Healthy Adult Volunteers

Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence

(2011) David P. Nicolau et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Epileptogenic Potential of Carbapenem Agents: Mechanism of Action, Seizure Rates, and Clinical Considerations

(2011) April D Miller et al.   PHARMACOTHERAPY

Central Nervous System Toxicity Associated with Ertapenem Use

(2010) Susan Duquaine et al.   ANNALS OF PHARMACOTHERAPY

Sulphobutylether-β-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis

(2010) Olaf Burkhardt et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum- -lactamase-producing Gram-negative organisms

(2010) R. Bazaz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacokinetics of Ertapenem following Intravenous and Subcutaneous Infusions in Patients

(2009) D. Frasca et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis

(2008) A.J. Brink et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic models with Monte Carlo simulation

(2008) Christopher R. Frei et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Seizures associated with ertapenem use in patients with CNS disorders and renal insufficiency

(2008) Alberto E. Fica et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Seizures associated with ertapenem

(2007) Catherine Ong et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS